Time’s almost up to register for Eyes On Retina 2026!
From AMD and diabetic eye disease to arterial occlusions, choroidal tumors, and pediatric retina, Eyes On Retina 2026 covers the full spectrum of retina care in one day. Attend 8 clinical sessions from leading experts live on Saturday, October 17, all built around the latest treatment and imaging protocols. Plus, earn up to 5 CE/CME credits online at no cost to you!
New Content
The Digital Dilemma: Protecting Pediatric Vision in a Screen-Heavy World
Redefining Durability in nAMD: How nAMD Clinical Trials are Evaluating Durability in New Ways
Fleming Island, FL
Chesterfield Township, MI
How Long-Term Durability and Safety are Redefining GA Treatment Decisions
Join Drs. Vakharia and Brugger as they discuss how to utilize long-term GATHER2 and GALE data to guide patient selection and GA treatment decisions.
Benchmarking Your Contact Lens KPIs: What Top-Performing Practices Are Tracking
This article outlines which contact lens KPIs to track, how your optometry practice compares to industry benchmarks, and where to adjust to increase revenue.
Putting Scale to Work for Independent Optometry
Learn how IDOC Labs helps practices put global scale to work, with Clerra simplifying dispensing, reducing costs, and protecting margins.
Topics
Start the Conversation: A Free Myopia Toolkit for ECPs
Structure-Function Correlation in GA: Why Microperimetry Is Entering the Conversation
Reframing SLT as a First-Line Glaucoma Therapy
Emerging Therapies and Clinical Trials in Early Diabetic Retinopathy
Spot the subtle signs of mild NPDR sooner, stage it with confidence, and know when watching and waiting stops serving your diabetic patients.
Bausch + Lomb's oral dry AMD therapy advances to clinical evaluation
Company reports a constructive meeting with the FDA over a planned trial evaluating oral tonabersat; currently eyeing a 2027 timeframe for kickoff.
Glaukos reports positive 3-year, phase 3 Epioxa clinical outcomes
Long-term extension study demonstrates clinically meaningful visual outcomes and corneal stabilization with just one treatment.
GLP-1 drugs increase risk for periorbital changes
GLP-1 receptor agonist use associated with higher rates of brow ptosis, dermatochalasis and corrective oculofacial procedures.
Academy in NOLA: retina durability, gene therapies, and TED data lead clinical highlights
The Digital Dilemma: Protecting Pediatric Vision in a Screen-Heavy World
Explore how optometrists can address the impact of screen exposure on myopia progression and educate parents and patients on healthy digital device use.
Why the Best Retina Surgeons Keep Adapting Their Technique
Join Drs. Kitchens and Sridhar as they discuss how cross-institutional training broadens surgeons' perspectives and improves patient care.
Redefining Durability in nAMD: How nAMD Clinical Trials are Evaluating Durability in New Ways
Clinical Specialties
How Long-Term Durability and Safety are Redefining GA Treatment Decisions
Putting Scale to Work for Independent Optometry
Start the Conversation: A Free Myopia Toolkit for ECPs
Benchmarking Your Contact Lens KPIs: What Top-Performing Practices Are Tracking
This article outlines which contact lens KPIs to track, how your optometry practice compares to industry benchmarks, and where to adjust to increase revenue.
Beyond the Sales Rep: Understanding Who’s Who in Industry
Discover who does what inside industry and how knowing the differences can save you time, find research opportunities, address insurance issues, and more.
I Saw It on TV: DTC Pharma Marketing and the New Eyecare Patient
Sit down with Drs. Lang, Garlich, and Dierker to review the impact of direct-to-consumer (DTC) pharmaceutical marketing on eyecare patients.
